• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂和依托泊苷(VP - 16)治疗转移性肾上腺皮质癌。

Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16).

作者信息

Johnson D H, Greco F A

出版信息

Cancer. 1986 Nov 15;58(10):2198-202. doi: 10.1002/1097-0142(19861115)58:10<2198::aid-cncr2820581006>3.0.co;2-a.

DOI:10.1002/1097-0142(19861115)58:10<2198::aid-cncr2820581006>3.0.co;2-a
PMID:3756767
Abstract

Two patients with metastatic adrenal cortical carcinoma were treated with cisplatin and etoposide. Both achieved a partial remission after only one cycle. One patient had a "nonfunctioning" tumor that had previously regressed on mitotane whereas the second patient presented with classical Cushing's syndrome. Although the latter patient's urinary 17-ketosteroids normalized while receiving mitotane, the tumor itself failed to regress objectively. Cisplatin plus etoposide appears to be an active combination for the treatment of metastatic adrenal cortical carcinoma.

摘要

两名转移性肾上腺皮质癌患者接受了顺铂和依托泊苷治疗。仅一个周期后两人均实现部分缓解。一名患者患有“无功能”肿瘤,此前米托坦治疗使其消退,而另一名患者表现为典型的库欣综合征。尽管后一名患者在接受米托坦治疗时尿17-酮类固醇恢复正常,但肿瘤本身并未客观消退。顺铂加依托泊苷似乎是治疗转移性肾上腺皮质癌的有效联合方案。

相似文献

1
Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16).顺铂和依托泊苷(VP - 16)治疗转移性肾上腺皮质癌。
Cancer. 1986 Nov 15;58(10):2198-202. doi: 10.1002/1097-0142(19861115)58:10<2198::aid-cncr2820581006>3.0.co;2-a.
2
Treatment of metastatic adrenal cortical carcinoma with etoposide (VP-16) and cisplatin after failure with o,p'DDD. Clinical case reports.在o,p'DDD治疗失败后,用依托泊苷(VP - 16)和顺铂治疗转移性肾上腺皮质癌。临床病例报告。
Am J Clin Oncol. 1996 Jun;19(3):229-31. doi: 10.1097/00000421-199606000-00003.
3
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.顺铂和依托泊苷序贯米托坦用于局部晚期或转移性肾上腺皮质癌患者疾病进展时的II期评估:一项西南肿瘤协作组研究
Cancer. 2000 Mar 1;88(5):1159-65.
4
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.米托坦联合依托泊苷、阿霉素和顺铂治疗晚期肾上腺皮质癌。意大利肾上腺癌研究小组。
Cancer. 1998 Nov 15;83(10):2194-200.
5
Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.
J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148.
6
Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.米托坦与顺铂、依托泊苷和阿霉素联合用于晚期儿童肾上腺皮质癌:米托坦监测与肿瘤消退
J Pediatr Hematol Oncol. 2006 Aug;28(8):513-24. doi: 10.1097/01.mph.0000212965.52759.1c.
7
Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.转移性肾上腺皮质癌对依托泊苷、阿霉素和顺铂(EAP)化疗的良好反应。两例报告。
Tumori. 1992 Oct 31;78(5):345-8. doi: 10.1177/030089169207800512.
8
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.转移性肾上腺皮质癌联合化疗与手术切除的II期试验:持续输注阿霉素、长春新碱和依托泊苷,每日服用米托坦作为P-糖蛋白拮抗剂。
Cancer. 2002 May 1;94(9):2333-43. doi: 10.1002/cncr.10487.
9
Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma.依托泊苷和顺铂用于晚期肾上腺皮质癌的细胞毒性治疗
Br J Cancer. 1998 Aug;78(4):546-9. doi: 10.1038/bjc.1998.530.
10
Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.米托坦与依托泊苷、阿霉素和顺铂联合化疗用于晚期肾上腺皮质癌患者的可行性。7例报告。
Ann Oncol. 1995 May;6(5):509-10. doi: 10.1093/oxfordjournals.annonc.a059224.

引用本文的文献

1
Chloroquine alleviates etoposide-induced centrosome amplification by inhibiting CDK2 in adrenocortical tumor cells.氯喹通过抑制肾上腺皮质肿瘤细胞中的CDK2来减轻依托泊苷诱导的中心体扩增。
Oncogenesis. 2015 Dec 21;4(12):e180. doi: 10.1038/oncsis.2015.37.
2
Adrenocortical tumors in children 18 years old and younger.18岁及以下儿童的肾上腺皮质肿瘤。
J Korean Surg Soc. 2012 Apr;82(4):246-50. doi: 10.4174/jkss.2012.82.4.246. Epub 2012 Mar 27.
3
Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer.
长春新碱、顺铂、替尼泊苷和环磷酰胺联合治疗复发性或转移性肾上腺皮质癌。
Med Oncol. 2004;21(2):167-77. doi: 10.1385/MO:21:2:167.
4
Adrenal cortical carcinoma.
Curr Treat Options Oncol. 2001 Aug;2(4):355-64. doi: 10.1007/s11864-001-0029-1.
5
Current perspective in the diagnosis and treatment of adrenocortical carcinoma.肾上腺皮质癌诊断与治疗的当前观点
Rev Endocr Metab Disord. 2001 Aug;2(3):323-33. doi: 10.1023/a:1011576702293.
6
Cytotoxic treatment of adrenocortical carcinoma.肾上腺皮质癌的细胞毒性治疗
World J Surg. 2001 Jul;25(7):927-33. doi: 10.1007/s00268-001-0031-6.
7
Adrenal cortical carcinoma.肾上腺皮质癌
World J Surg. 2001 Jul;25(7):914-26. doi: 10.1007/s00268-001-0030-7.
8
[Drug therapy of endocrine neoplasms. Part I: Thyroid neoplasms, adrenal neoplasms and parathyroid neoplasms].[内分泌肿瘤的药物治疗。第一部分:甲状腺肿瘤、肾上腺肿瘤和甲状旁腺肿瘤]
Med Klin (Munich). 2000 Jan 15;95(1):20-5. doi: 10.1007/BF03044976.
9
Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma.依托泊苷和顺铂用于晚期肾上腺皮质癌的细胞毒性治疗
Br J Cancer. 1998 Aug;78(4):546-9. doi: 10.1038/bjc.1998.530.
10
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients.米托坦治疗肾上腺皮质癌的最佳方案:96例连续病例的结果
Br J Cancer. 1994 May;69(5):947-51. doi: 10.1038/bjc.1994.183.